# Effects of Esketamine on Consciousness-related Brain Network Characteristics in Patients With Prolonged Disorders of Consciousness

> **NCT06473285** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Prolonged Disorders of Consciousness

## Interventions

- **DRUG:** Drug: Esketamine (Continuous infusion)

## Key facts

- **NCT ID:** NCT06473285
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06473285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06473285, "Effects of Esketamine on Consciousness-related Brain Network Characteristics in Patients With Prolonged Disorders of Consciousness". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06473285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*